MM
Magnus Medical, Inc.
SEC filingBiotechnology · Burlingame, CA
Amount raised$49Msold at filing
Total offering$77M$28M still open
Investors in the raise10count reported to the SEC
FiledMay 26, 2026first sale May 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Heath LukatchDirector
Andrew FirlikDirector
Achal AchrolExecutive Officer, Director
Brandon BentzleyExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.